SARS-CoV-2 Prevalence among People Living with HIV: Preliminary Results from Selected Sentinel Counties in Kenya, February−June 2021

This report was prepared by the Kenya Medical Research Institute (KEMRI) Centre for Global Health Research (CGHR) HIV Research Laboratory, U.S Centers for Disease Control and Prevention (CDC, Division of Global HIV & TB, Amref Health Africa, and the Kenya Ministry of Health; August 2022.

The study was undertaken to determine the seroprevalence of SARSCoV-2 antibodies in PLHIV receiving anti-retroviral therapy (ART) in five selected counties in Kenya. Findings can be used to understand the burden of SARS-CoV-2 infection among PLHIV and inform health policy.